Madeleine Johnson

The firm plans to apply more than $10 million in recent Gates Foundation grants toward regulatory submission of a rapid STI test.

The firm expects Sherlock's chlamydia and gonorrhea self-test to contribute to its growth in 2026, pending FDA clearance.

The USDA will expand a milk surveillance program using molecular methods in light of increasing infections of animals and humans.

In the wake of suspending guidance to review the business in the first quarter of the year, QuidelOrtho has restructured and resumed offering a financial outlook.

Sales in the QiaStat-Dx syndromic testing franchise increased 40 percent following recent menu expansion.

Bio-Rad confirmed its full-year guidance, reflecting a slower gradual pace of biopharma end market recovery and growth for the clinical diagnostics group.

A team in Australia developed a method using an open-source PCR system and proposed a theoretical framework for on-the-fly PCR optimization.

The firm launched the QiAcuityDx system on Monday and will seek US Food and Drug Administration 510(k) clearance along with a BCR-ABL assay.

The PCR and AI-based method from Dutch microbiology diagnostics developer Inbiome can identify more than 200 bacterial organisms in less than four hours.

The firm will enter clinical trials in November for a combined flu, RSV, and COVID test and expects to debut additional small syndromic panels later.